- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有394家主力机构披露2025-06-30报告期持股数据，持仓量总计2.88亿股，占流通A股20.38%
- 波段诊断：
-
技术面诊股
平均成本
近期的平均成本为20.89元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"20.89","date":1762330359,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2025.11.06","stock":"-1.47","trade":"-0.33","ind":"1.73"},{"date":"2025.11.05","stock":"-0.85","trade":"-0.81","ind":"0.37"},{"date":"2025.11.04","stock":"2.80","trade":"-0.81","ind":"-1.71"},{"date":"2025.11.03","stock":"0.58","trade":"0.04","ind":"0.19"},{"date":"2025.10.31","stock":"3.05","trade":"4.09","ind":"-1.14"},{"date":"2025.10.30","stock":"-1.33","trade":"-0.83","ind":"-1.16"},{"date":"2025.10.29","stock":"1.10","trade":"1.00","ind":"1.95"},{"date":"2025.10.28","stock":"-0.94","trade":"0.24","ind":"-0.44"},{"date":"2025.10.27","stock":"0.15","trade":"0.61","ind":"1.51"},{"date":"2025.10.24","stock":"0.10","trade":"0.39","ind":"2.02"},{"date":"2025.10.23","stock":"-0.25","trade":"-1.29","ind":"0.22"},{"date":"2025.10.22","stock":"-0.15","trade":"-0.28","ind":"-0.62"},{"date":"2025.10.21","stock":"1.10","trade":"1.45","ind":"2.06"},{"date":"2025.10.20","stock":"-0.10","trade":"0.44","ind":"0.98"},{"date":"2025.10.17","stock":"-2.53","trade":"-1.55","ind":"-3.04"},{"date":"2025.10.16","stock":"-1.06","trade":"0.01","ind":"-0.25"},{"date":"2025.10.15","stock":"1.51","trade":"2.13","ind":"1.73"},{"date":"2025.10.14","stock":"-0.53","trade":"-1.02","ind":"-2.54"},{"date":"2025.10.13","stock":"-1.53","trade":"-1.02","ind":"-0.93"},{"date":"2025.10.10","stock":"-0.24","trade":"-0.88","ind":"-2.70"},{"date":"2025.10.09","stock":"0.96","trade":"-0.38","ind":"1.47"}]
智飞生物,深证成指,生物制品指数
压力支撑
该股压力位为20.92元，支撑位为20.71元。
[{"text":"\u538b\u529b\u4f4d","value":"20.92","date":1762358400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"20.71","date":1762358400,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.1资金面打败了8%的股票
主力控盘前10的股票
行业资金
生物制品行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月06日 20:30
| 机构今日流向(万元) | -1318.34 | 机构5日流向(万元) | -1690.93 |
| 机构10日流向(万元) | -3511.21 | 机构20日流向(万元) | -13363.70 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少4367.02万股，其中基金净减仓145家，主力净减仓17家，请投资者中长期谨慎为宜。
截止2025-06-30，共394家主力机构（基金392家，一般法人2家），持仓量总计28823.73万股，占流通A股20.38%
其中，基金持仓与2024-12-31相比：
增仓：54家 ，增持 534.75万股
减仓：199家 ，减持 2547.10万股
新出现在主力名单中：110家 ，持有756.37万股
从主力名单中消失：127家 ，原持有1627.64万股
其中，基金持仓与2024-12-31相比：
增仓：54家 ，增持 534.75万股
减仓：199家 ，减持 2547.10万股
新出现在主力名单中：110家 ，持有756.37万股
从主力名单中消失：127家 ，原持有1627.64万股
消息面诊股
诊断结果：5.5消息面打败了29%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 智飞生物迷雾重重：“高费用+高存货”，留下的基金巨
2025-11-06 - 智飞生物：11月5日获融资买入8195.10万元
2025-11-06 - 智飞生物：11月4日获融资买入1.50亿元
2025-11-05 - 疫苗板块短线拉升，华兰疫苗涨超10%
2025-11-04 - 智飞生物：11月3日获融资买入5045.71万元
2025-11-04 - 14只医药股应收账款超百亿元，血液制品企业普遍大增
2025-11-03 - 2025年Q3基金持仓智飞生物明细
2025-11-03 - 智飞生物：行业波动下韧性十足 增量挖潜与自主创新成
2025-11-03 - 智飞生物：10月31日获融资买入9326.25万元
2025-11-03 - 智飞生物2025年三季报凸显产业韧性 自研管线兑现
2025-11-01
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-30 |
| 一般消息 | 高管变动 | 因公司治理结构及内部工作调整 | 2025-10-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-19 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-08-19 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-19 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-20 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-22 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-22 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-24 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：6.8行业面打败了91%的股票
生物制品行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2025.11.06","price":"1.73","value":"-0.33"},{"date":"2025.11.05","price":"0.37","value":"-0.81"},{"date":"2025.11.04","price":"-1.71","value":"-0.81"},{"date":"2025.11.03","price":"0.19","value":"0.04"},{"date":"2025.10.31","price":"-1.14","value":"4.09"},{"date":"2025.10.30","price":"-1.16","value":"-0.83"},{"date":"2025.10.29","price":"1.95","value":"1.00"},{"date":"2025.10.28","price":"-0.44","value":"0.24"},{"date":"2025.10.27","price":"1.51","value":"0.61"},{"date":"2025.10.24","price":"2.02","value":"0.39"},{"date":"2025.10.23","price":"0.22","value":"-1.29"},{"date":"2025.10.22","price":"-0.62","value":"-0.28"},{"date":"2025.10.21","price":"2.06","value":"1.45"},{"date":"2025.10.20","price":"0.98","value":"0.44"},{"date":"2025.10.17","price":"-3.04","value":"-1.55"},{"date":"2025.10.16","price":"-0.25","value":"0.01"},{"date":"2025.10.15","price":"1.73","value":"2.13"},{"date":"2025.10.14","price":"-2.54","value":"-1.02"},{"date":"2025.10.13","price":"-0.93","value":"-1.02"},{"date":"2025.10.10","price":"-2.70","value":"-0.88"},{"date":"2025.10.09","price":"1.47","value":"-0.38"}]
深证成指,生物制品行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 华兰疫苗 | 36.24% | 22.56% | 5.7分 |
| 2 | 三生国健 | 30.47% | 13.82% | 6.6分 |
| 3 | 万泽股份 | 29.88% | 21.56% | 6.7分 |
| 4 | 我武生物 | 15.04% | -1.48% | 5.5分 |
| 5 | 金迪克 | 13.93% | 9.19% | 5.5分 |
| 6 | - | 12.80% | 0.58% | 分 |
| 8 | 东宝生物 | 7.33% | 7.13% | 5.8分 |
| 10 | *ST双成 | 6.77% | 0.49% | 5.3分 |
| 12 | 赛升药业 | 6.38% | 2.83% | 5.1分 |
| 14 | 优宁维 | 5.02% | 4.11% | 5.8分 |
| 16 | 华兰生物 | 3.89% | 3.10% | 6.1分 |
| 18 | 辽宁成大 | 3.45% | 2.63% | 6.6分 |
| 20 | 赛伦生物 | 3.08% | 1.13% | 6.2分 |
| 22 | 义翘神州 | 2.60% | 3.24% | 5.5分 |
| 24 | 昊帆生物 | 2.37% | -0.15% | 5.9分 |
| 26 | 成大生物 | 1.03% | 1.14% | 5.5分 |
| 28 | 上海莱士 | 0.44% | 1.49% | 5.8分 |
| 30 | 康泰生物 | -0.41% | 1.08% | 5.2分 |
| 32 | 诺唯赞 | -0.87% | -0.26% | 5.7分 |
| 34 | 百克生物 | -1.22% | 0.74% | 5.3分 |
| 36 | 智翔金泰 | -2.89% | -1.55% | 5.3分 |
| 38 | 科兴制药 | -4.10% | -4.91% | 6.0分 |
| 40 | 康希诺 | -4.90% | -1.66% | 5.2分 |
| 42 | 迈威生物 | -6.14% | 5.20% | 6.1分 |
| 44 | 百奥泰 | -6.35% | 0.15% | 5.7分 |
| 46 | 特宝生物 | -9.88% | 3.60% | 6.1分 |
| 48 | 康辰药业 | -11.95% | -1.81% | 5.3分 |
| 50 | 甘李药业 | -14.16% | -7.10% | 5.5分 |
| 52 | 欧林生物 | -16.92% | -2.47% | 6.6分 |
| 54 | 禾元生物 | - | -13.31% | 3.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，两项指标的行业排名分别为 43/72 ， 49/72。
[{"date":"2025-09-30","value":"-4.01","vol":"-9.95"},{"date":"2025-06-30","value":"-1.96","vol":"-0.61"},{"date":"2025-03-31","value":"-0.99","vol":"0.46"},{"date":"2024-12-31","value":"6.48","vol":"-0.68"},{"date":"2024-09-30","value":"6.83","vol":"1.34"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-4.01 | -1.96 | -0.99 | 6.48 | 6.83 |
| 行业(%) | -9.95 | -0.61 | 0.46 | -0.68 | 1.34 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"23.77","vol":"67.19"},{"date":"2025-06-30","value":"28.34","vol":"68.28"},{"date":"2025-03-31","value":"32.19","vol":"68.43"},{"date":"2024-12-31","value":"27.38","vol":"69.85"},{"date":"2024-09-30","value":"27.23","vol":"70.47"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
23.77 | 28.34 | 32.19 | 27.38 | 27.23 |
| 行业(%) | 67.19 | 68.28 | 68.43 | 69.85 | 70.47 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 51/72 ， 46/72。
[{"date":"2025-09-30","value":"-66.53","vol":"44.96"},{"date":"2025-06-30","value":"-73.06","vol":"6902.04"},{"date":"2025-03-31","value":"-79.16","vol":"6125.27"},{"date":"2024-12-31","value":"-50.74","vol":"47.35"},{"date":"2024-09-30","value":"-41.98","vol":"175.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-66.53 | -73.06 | -79.16 | -50.74 | -41.98 |
| 行业(%) | 44.96 | 6902.04 | 6125.27 | 47.35 | 175.00 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-156.86","vol":"44.17"},{"date":"2025-06-30","value":"-126.72","vol":"5.44"},{"date":"2025-03-31","value":"-120.93","vol":"-8.46"},{"date":"2024-12-31","value":"-74.99","vol":"-9.81"},{"date":"2024-09-30","value":"-67.07","vol":"-52.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-156.86 | -126.72 | -120.93 | -74.99 | -67.07 |
| 行业(%) | 44.17 | 5.44 | -8.46 | -9.81 | -52.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，两项指标的行业排名分别为 34/72 ， 46/72。
[{"date":"2025-09-30","value":"0.16","vol":"0.22"},{"date":"2025-06-30","value":"0.10","vol":"0.14"},{"date":"2025-03-31","value":"0.05","vol":"0.06"},{"date":"2024-12-31","value":"0.52","vol":"0.29"},{"date":"2024-09-30","value":"0.44","vol":"0.22"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.16 | 0.10 | 0.05 | 0.52 | 0.44 |
| 行业(次) | 0.22 | 0.14 | 0.06 | 0.29 | 0.22 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.27","vol":"0.91"},{"date":"2025-06-30","value":"0.16","vol":"0.56"},{"date":"2025-03-31","value":"0.07","vol":"0.26"},{"date":"2024-12-31","value":"1.21","vol":"1.17"},{"date":"2024-09-30","value":"1.12","vol":"0.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.27 | 0.16 | 0.07 | 1.21 | 1.12 |
| 行业(次) | 0.91 | 0.56 | 0.26 | 1.17 | 0.86 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"52.46","vol":"1.99"},{"date":"2025-06-30","value":"49.52","vol":"-1377.61"},{"date":"2025-03-31","value":"12.81","vol":"-46.99"},{"date":"2024-12-31","value":"-41.09","vol":"-11.33"},{"date":"2024-09-30","value":"-60.90","vol":"-30.88"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 52.46 | 49.52 | 12.81 | -41.09 | -60.90 |
| 行业 | 1.99 | -1377.61 | -46.99 | -11.33 | -30.88 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.00","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.30","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.00 | - | 2.30 | - |
| 行业 | 0.00 | 1.59 | 0.00 | 2.01 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，居行业前列，两项指标的行业排名分别为 11/72 ， 6/72。
[{"date":"2025-09-30","value":"2.80","vol":"5.99"},{"date":"2025-06-30","value":"2.45","vol":"6.64"},{"date":"2025-03-31","value":"2.30","vol":"7.75"},{"date":"2024-12-31","value":"2.24","vol":"6.72"},{"date":"2024-09-30","value":"2.10","vol":"7.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.80 | 2.45 | 2.30 | 2.24 | 2.10 |
| 行业 | 5.99 | 6.64 | 7.75 | 6.72 | 7.02 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.23","vol":"4.82"},{"date":"2025-06-30","value":"1.06","vol":"5.30"},{"date":"2025-03-31","value":"1.03","vol":"6.35"},{"date":"2024-12-31","value":"1.03","vol":"5.40"},{"date":"2024-09-30","value":"1.14","vol":"5.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.23 | 1.06 | 1.03 | 1.03 | 1.14 |
| 行业 | 4.82 | 5.30 | 6.35 | 5.40 | 5.66 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 11/72 ， 14/72。
[{"date":"2025-09-30","value":"36.18","vol":"28.14"},{"date":"2025-06-30","value":"34.18","vol":"26.73"},{"date":"2025-03-31","value":"36.85","vol":"26.03"},{"date":"2024-12-31","value":"38.23","vol":"25.81"},{"date":"2024-09-30","value":"41.46","vol":"24.44"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
36.18 | 34.18 | 36.85 | 38.23 | 41.46 |
| 行业(%) | 28.14 | 26.73 | 26.03 | 25.81 | 24.44 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.57","vol":"0.58"},{"date":"2025-06-30","value":"0.52","vol":"1.11"},{"date":"2025-03-31","value":"0.58","vol":"0.78"},{"date":"2024-12-31","value":"0.62","vol":"0.87"},{"date":"2024-09-30","value":"0.71","vol":"0.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.57 | 0.52 | 0.58 | 0.62 | 0.71 |
| 行业(%) | 0.58 | 1.11 | 0.78 | 0.87 | 0.40 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"102.09","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"75.39","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"80.70","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"20.18","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"12.86","blueLineValue":"0.54","type":"YC"}]